AVAC

Scientific progress is built one discovery at a time.

In their latest article, Stacey Hannah, Director of Research Engagement at AVAC, and Mitchell Warren, AVAC's Executive Director, remind us that while today's HIV prevention tools are transforming lives, ending the epidemic will require continued innovation. An HIV vaccine remains one of our greatest opportunities to achieve lasting, global impact.

Every advance depends on decades of research, sustained investment, and the volunteers who make clinical studies possible. Continued support for HIV vaccine research is essential to building on the progress we've made and moving closer to a world without HIV.

Read the full article: https://www.thinkglobalhealth.org/article/nih-budget-cuts-threaten-hiv-research?utm_source=thinkglobalhealth&